TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 173 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2021. The put-call ratio across all filers is 4.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $11,925,000 | -48.7% | 250,000 | -28.6% | 0.32% | -37.7% |
| Q3 2021 | $23,251,000 | -14.9% | 350,000 | 0.0% | 0.52% | -6.1% |
| Q2 2021 | $27,307,000 | -7.7% | 350,000 | +11.9% | 0.55% | +5.9% |
| Q1 2021 | $29,578,000 | -30.6% | 312,700 | -10.7% | 0.52% | -42.9% |
| Q4 2020 | $42,648,000 | +50.2% | 350,000 | +7.7% | 0.92% | +32.9% |
| Q3 2020 | $28,392,000 | +25.6% | 325,000 | -7.1% | 0.69% | +8.8% |
| Q2 2020 | $22,607,000 | +68.7% | 350,000 | +16.7% | 0.63% | +11.8% |
| Q1 2020 | $13,398,000 | -28.3% | 300,000 | 0.0% | 0.57% | -21.6% |
| Q4 2019 | $18,687,000 | +24.2% | 300,000 | -25.0% | 0.72% | +19.7% |
| Q3 2019 | $15,040,000 | +84.8% | 400,000 | +100.0% | 0.60% | +83.3% |
| Q2 2019 | $8,140,000 | – | 200,000 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 3,037,042 | $236,950,000 | 8.05% |
| MPM BioImpact LLC | 269,186 | $21,002,000 | 3.45% |
| Logos Global Management LP | 400,000 | $31,208,000 | 2.62% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 121,541 | $9,481,000 | 2.50% |
| Orbimed Advisors | 2,361,327 | $184,231,000 | 1.86% |
| First Light Asset Management, LLC | 395,825 | $30,882,000 | 1.85% |
| SECTORAL ASSET MANAGEMENT INC | 211,650 | $16,513,000 | 1.34% |
| Nicholas Investment Partners, LP | 224,876 | $17,545,000 | 1.10% |
| DAFNA Capital Management LLC | 47,852 | $3,733,000 | 0.78% |
| Eventide Asset Management | 578,000 | $45,096,000 | 0.61% |